BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 25450235)

  • 1. Galangin inhibits growth of human head and neck squamous carcinoma cells in vitro and in vivo.
    Zhu L; Luo Q; Bi J; Ding J; Ge S; Chen F
    Chem Biol Interact; 2014 Dec; 224():149-56. PubMed ID: 25450235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SKLB188 inhibits the growth of head and neck squamous cell carcinoma by suppressing EGFR signalling.
    Barzegar M; Ma S; Zhang C; Chen X; Gu Y; Shang C; Jiang X; Yang J; Nathan CA; Yang S; Huang S
    Br J Cancer; 2017 Oct; 117(8):1154-1163. PubMed ID: 28873083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma.
    Ku BM; Yi SY; Koh J; Bae YH; Sun JM; Lee SH; Ahn JS; Park K; Ahn MJ
    Oncotarget; 2016 Mar; 7(12):14803-13. PubMed ID: 26909611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK4/6 inhibitor-SHR6390 exerts potent antitumor activity in esophageal squamous cell carcinoma by inhibiting phosphorylated Rb and inducing G1 cell cycle arrest.
    Wang J; Li Q; Yuan J; Wang J; Chen Z; Liu Z; Li Z; Lai Y; Gao J; Shen L
    J Transl Med; 2017 Jun; 15(1):127. PubMed ID: 28578693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of UCN-01 in carcinomas of the head and neck is associated with altered expression of cyclin D3 and p27(KIP1).
    Patel V; Lahusen T; Leethanakul C; Igishi T; Kremer M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS; Senderowicz AM
    Clin Cancer Res; 2002 Nov; 8(11):3549-60. PubMed ID: 12429646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma.
    Mishra PB; Lobo AS; Joshi KS; Rathos MJ; Kumar GA; Padigaru M
    J Transl Med; 2013 Feb; 11():42. PubMed ID: 23414419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.
    Patel V; Senderowicz AM; Pinto D; Igishi T; Raffeld M; Quintanilla-Martinez L; Ensley JF; Sausville EA; Gutkind JS
    J Clin Invest; 1998 Nov; 102(9):1674-81. PubMed ID: 9802881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.
    Prasad R; Katiyar SK
    PLoS One; 2012; 7(9):e46404. PubMed ID: 23050025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin suppresses growth of human head and neck squamous cell carcinoma via global inhibition of protein translation.
    Sikka A; Kaur M; Agarwal C; Deep G; Agarwal R
    Cell Cycle; 2012 Apr; 11(7):1374-82. PubMed ID: 22421144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic anti-cancer effects of galangin and berberine through apoptosis induction and proliferation inhibition in oesophageal carcinoma cells.
    Ren K; Zhang W; Wu G; Ren J; Lu H; Li Z; Han X
    Biomed Pharmacother; 2016 Dec; 84():1748-1759. PubMed ID: 27876206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anticancer agent, SKLB70359, inhibits human hepatic carcinoma cells proliferation via G0/G1 cell cycle arrest and apoptosis induction.
    Dai XY; Zeng XX; Peng F; Han YY; Lin HJ; Xu YZ; Zhou T; Xie G; Deng Y; Mao YQ; Yu LT; Yang L; Zhao YL
    Cell Physiol Biochem; 2012; 29(1-2):281-90. PubMed ID: 22415097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells.
    Lim YC; Lee SH; Song MH; Yamaguchi K; Yoon JH; Choi EC; Baek SJ
    Eur J Cancer; 2006 Dec; 42(18):3260-6. PubMed ID: 17045795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck.
    Amornphimoltham P; Patel V; Sodhi A; Nikitakis NG; Sauk JJ; Sausville EA; Molinolo AA; Gutkind JS
    Cancer Res; 2005 Nov; 65(21):9953-61. PubMed ID: 16267020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma.
    Jiang L; Wu X; Wang P; Wen T; Yu C; Wei L; Chen H
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):971-81. PubMed ID: 25391371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cells.
    Gao X; Han L; Ding N; Mu Y; Guan P; Hu C; Huang X
    J Antibiot (Tokyo); 2018 Sep; 71(9):808-817. PubMed ID: 29752478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulated cyclin D1 expression is associated with decreased efficacy of the selective epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in head and neck squamous cell carcinoma cell lines.
    Kalish LH; Kwong RA; Cole IE; Gallagher RM; Sutherland RL; Musgrove EA
    Clin Cancer Res; 2004 Nov; 10(22):7764-74. PubMed ID: 15570011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-encapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway.
    Wang D; Veena MS; Stevenson K; Tang C; Ho B; Suh JD; Duarte VM; Faull KF; Mehta K; Srivatsan ES; Wang MB
    Clin Cancer Res; 2008 Oct; 14(19):6228-36. PubMed ID: 18829502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cyclin D1 by shRNA is associated with enhanced sensitivity to conventional therapies for head and neck squamous cell carcinoma.
    Kothari V; Mulherkar R
    Anticancer Res; 2012 Jan; 32(1):121-8. PubMed ID: 22213296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of novel compound, guttiferone K, on colon cancer by p21Waf1/Cip1-mediated G(0) /G(1) cell cycle arrest and apoptosis.
    Kan WL; Yin C; Xu HX; Xu G; To KK; Cho CH; Rudd JA; Lin G
    Int J Cancer; 2013 Feb; 132(3):707-16. PubMed ID: 22733377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.